Interestingly, the proteins S100A8, S100A9, and S100A12, which were dysregulated in RA monocytes based on transcript data, can be regulated by epigenetic drugs such as budesonide and RG108, suggesting their potential use in targeting inflammation in RA. Here, S100A8 is linked to rheumatoid arthritis.